GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppression
Preprint in bioRxiv (February 2024)
The most recent citing publications are shown below. View all 70 publications that cite this research output on Dimensions.
Preprint in bioRxiv (February 2024)
Article in Molecular Psychiatry (February 2024)
Article in Molecular Psychiatry (January 2024)